Matthew R. Stober is the President and Chief Executive Officer of Istari Oncology. With more than 30 years of leadership experience at large, multinational pharmaceutical organizations, Mr. Stober has led multiple strategic corporate transactions, including major acquisitions and divestitures.
Garrett Nichols, MD, MS, is the Chief Medical Officer at Istari Oncology. With more than 20 years in the life sciences industry, Dr. Nichols brings vast experience managing the global development efforts of multiple cancer therapeutics stemming from his achievements at large, multinational pharmaceutical organizations to his role at the company.
Jamie Iudica is the Chief Manufacturing Officer at Istari Oncology. With more than 25 years in the pharmaceutical industry, Mr. Iudica brings a wide range of leadership experience in engineering, manufacturing, and supply-chain operation to his role at the company.
Lauren Neighbours, PhD, RAC, is the Vice President of Regulatory Affairs at Istari Oncology. With more than 13 years of life science research experience working for organizations of various types and sizes, Dr. Neighbours brings a rich knowledge of regulatory strategy and compliance to her role at the company.
Shannon Morris, MD, PhD, is the Vice President of Clinical Development at Istari Oncology. With more than 15 years in the life sciences industry, Dr. Morris brings a deep level of industry experience in the clinical research and development fields to her role at the company.
Sarah Krepp, SPHR, is Senior Vice President of Human Resources and Administration at Istari Oncology. With more than 17 years of biological and human resource experience in start-up, midsized pharmaceutical, and clinical research organizations, Ms. Krepp brings seasoned experience to her leadership role at the company.
Matt Farber, CPA, is the Vice President of Finance at Istari Oncology. With more than 25 years of experience, Matt brings an expansive knowledge of both public and industry accounting and finance experience to his role at the company.
Mr. Higgins is the Vice President of Corporate and Commercial Development at Istari Oncology. With 30 years of extensive commercial experience, Mr. Higgins brings a deep understanding of oncology and rare disease to his role, including a proven track record spanning commercial operations, strategic planning, product launches, and sales achievements across the full product life cycle.
Rob Melfi is Chief of Staff and Director, Program Management at Istari Oncology, where he focuses on the development and execution of strategic initiatives across programs and functions. Mr. Melfi brings more than 7 years of experience in strategy development and execution, process analysis and improvement, quantitative and qualitative evaluation of strategic options, and program stakeholder management to his role at the company.